
Takeda receives CHMP recommendation for Adcetris in Hodgkin lymphoma
Takeda has received a new recommendation from the European Medicines Agency’s human medicines committee for its Pfizer-partnered blood cancer drug Adcetris (brentuximab vedotin). The Committee for Medicinal Products for Human Use (CHMP) has recommended …